• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Understanding the potential impact of the upcoming ACIP vote on thimerosal-containing influenza vaccines

Understanding the potential impact of the upcoming ACIP vote on thimerosal-containing influenza vaccines

by Truveta Research | Jun 26, 2025 | Research, Research Insights

Thimerosal is a preservative contained in some vaccines, which has been used and considered safe for decades. During the June 2025 ACIP meeting, a presentation and vote on the use of thimerosal is scheduled to take place. During the 2024-2025 respiratory virus season,...
Biosimilar use is on the rise – but 1 in 8 patients return to Humira

Biosimilar use is on the rise – but 1 in 8 patients return to Humira

by Truveta Research | Jun 23, 2025 | Research, Research Insights

Switching from bio-originator Humira to a biosimilar peaked in April 2024 – the month an important formulary change took effect – and remains higher than 2023, suggesting growing adoption of biosimilars. More than 1 in 8 patients who initiated a biosimilar...
New study finds GLP-1 RA medications may significantly reduce risk of alcohol-related hospitalization

New study finds GLP-1 RA medications may significantly reduce risk of alcohol-related hospitalization

by Truveta Research | Jun 13, 2025 | Research, Research Insights

Truveta and collaborators partnered on a new large-scale study that considers the potential benefits of GLP-1 RA for AUD, among those with diabetes and/or obesity. Using a target trial emulation framework, researchers analyzed Truveta Data and compared adults with...
Shifting trends in TKA fixation: Real-world evidence on the changing landscape of cemented vs uncemented TKA

Shifting trends in TKA fixation: Real-world evidence on the changing landscape of cemented vs uncemented TKA

by Truveta Research | Jun 5, 2025 | Research, Research Insights

The percentage of uncemented total knee arthroplasties (TKAs) nearly doubled from 5.7% to 10.3% between 2018 and 2024. Readmission and revision rates were similar between cemented and uncemented TKAs. Cemented TKAs were associated with higher rates of stiffness,...
ASCO 2025: Development and validation of machine learning risk prediction models for detection of early-onset colorectal cancer

ASCO 2025: Development and validation of machine learning risk prediction models for detection of early-onset colorectal cancer

by Truveta staff | May 30, 2025 | Research, Research Insights

Authors: Wilson Lau, PhD ⊕Truveta, Inc, Bellevue, WA,, Youngwon Kim, PhD ⊕Truveta, Inc, Bellevue, WA, Sravanthi Paras, MD ⊕Swedish Medical Center, Seattle, WA, Md Enamul Haque, PhD ⊕Truveta, Inc, Bellevue, WA,, Sara Daraei, PhD ⊕Truveta, Inc, Bellevue, WA, Rajesh Rao,...
« Older Entries

Share this


Recent posts

  • Real-world survival outcomes for CRT and CCM therapies align with landmark trials
  • Understanding the potential impact of the upcoming ACIP vote on thimerosal-containing influenza vaccines
  • Biosimilar use is on the rise – but 1 in 8 patients return to Humira

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice